Why study the Master's Degree in Pharma-Biotech Business Management?
What will you learn?
The Master's Degree in Pharma-Biotech Company Management seeks to train specialised and versatile professionals with the capacity for analysis and reflection, with personal qualities that add value to business: teamwork, dynamic, proactive and flexible attitude and that, at the same time, maintain an ethical attitude in line with the social responsibility of the company.
To this end, the School has designed a training programme that combines a solid academic base (taught by professors and collaborators from the University of Navarra, the IESE Business School and professionals from the sector) and a period of paid internships at business.
With this Master's degree you will learn about finance, marketing, accounting and operations at business from university lecturers, business school professors and professionals from pharmaceutical companies. You will also learn to work, with a critical spirit, in management areas of the pharma-biotech industry and other related industries, while developing skills in communication, teamwork and people management.
As it is an official master's degree, it enables you to entrance to undertake doctoral studies..
Professional projection
The Pharma-Biotech sector has faced major changes in recent years that are generating a change of model and the rapid transformation of the sector: the irruption of the digital world in the value chain, new ways of communication and interaction with the patient, new ways of analysing and using data, reduction of product lifecycles, etc.
All these changes mean that the sector is demanding professionals with excellent scientific and business backgrounds who have developed skills such as resilience, flexibility, adaptability, negotiation and collaboration, global vision, analysis and decision-making.
|
Commercial |
Digital |
The programme uses the case method as a system of teaching, which consists of solving real problems involving thorough analysis of the facts and proposal of solutions and alternatives. To get the most out of it, student is required to prepare each case individually and then discuss it in a team before attend at discussion on class directed by the teacher. It is a process that enriches learning due to the contributions of the other class colleagues and the solution proposed by the teacher.
The profile of the students is varied, although they all share a biosanitary background: pharmacy, biotechnology, biomedical engineering, medicine, veterinary medicine, biochemistry, biology, biomedicine, chemistry, etc.
They come from both national and international universities: U. de Navarra, U. Complutense de Madrid, U. de Barcelona, U. de Alcalá de Henares, U. de Sevilla, U. Pompeu Fabra, U. CEU San Pablo, U. de Valencia, U. Politécnica de Madrid y de Valencia, U. College of London, Imperial College of London, U. Exeter, U. de Grenoble, among others.
The Pharma-Biotech sector has faced major changes in recent years that are generating a change of model and the rapid transformation of the sector: the irruption of the digital world in the value chain, new ways of communication and interaction with the patient, new ways of analysing and using data, reduction of product lifecycles, etc.
All these changes mean that the sector is demanding professionals with excellent scientific and business backgrounds who have developed skills such as resilience, flexibility, adaptability, negotiation and collaboration, global vision, analysis and decision-making.
|
Commercial |
Digital |
